Capricor says its cell therapy improved heart and muscle function in Duchenne patients The dual outcomes in a Phase 3 study will likely bolster the treatment’s regulatory future

https://www.statnews.com/2025/12/03/capricor-cell-therapy-improves-heart-function-duchenne-patients-phase-3-trial/